Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
about
Prevalence of monoclonal gammopathy of undetermined significance: a systematic reviewAdvances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myelomaMonoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyCharacterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis.Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and management.Waldenström macroglobulinemia: 2012 update on diagnosis, risk stratification, and management.Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management.Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management.Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management.Plasma cell neoplasia after kidney transplantation: French cohort series and review of the literature.Increased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis.Altered mRNA expression of telomere-associated genes in monoclonal gammopathy of undetermined significance and multiple myeloma.LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosisEvidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells.Characterization of monoclonal gammopathy of undetermined significance by calorimetric analysis of blood serum proteome.Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma.Five-Year Follow-up Study of Monoclonal Gammopathy of Undetermined Significance in a Korean Elderly Urban Cohort.Incidental finding of monoclonal gammopathy in blood donors: a follow-up study.Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whitesImmune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myelomaA case series of autoimmune diseases accompanied by incidentally diagnosed monoclonal gammopathy: is there a link between the two diseases?Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma.Monoclonal gammopathy of undetermined significance: a contraindication for living kidney donation?Multiple myeloma after kidney transplantation.Etanercept therapy in a hepatitis B virus (HBV)-positive psoriatic patient developing a monoclonal gammopathy of undetermined significance.Involved/uninvolved immunoglobulin ratio identifies monoclonal gammopathy of undetermined significance patients at high risk of progression to multiple myeloma.A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance.Abnormal Plasma Cell Disorders in Refinery Waste WorkersImproving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profilesMALDI-TOF analysis of blood serum proteome can predict the presence of monoclonal gammopathy of undetermined significance
P2860
Q24597406-859B5E72-7472-40E7-A43B-4E71E5ED448DQ24619589-69A68140-F63F-42A5-BADE-CEDF93311796Q24653006-DD171F30-2AD1-4DB0-844C-F00A2C95AA82Q30316799-8F4CA427-4772-4E24-97D7-F5997874C140Q33395066-0D51411E-AA35-471E-A886-AEF7904FBD16Q33400780-DC4C5509-CC1C-4441-935A-0FA5F5D72450Q33408517-E170AB6C-75CA-4F22-AFDA-C5C8612D2AD0Q33421444-473FDA16-5063-442D-82D3-CEAF989AF45BQ33438490-1285C166-D16A-449E-9FAC-225ABBFC6EEDQ33821866-C783DE57-E966-4CC4-B20E-5A20384D0CCBQ34091229-343F6FD3-8FDB-4DE5-BB90-24AED9B34314Q34274213-7F8CEB96-5627-4144-B1E8-6EC9DC61784CQ34282335-EB1CD227-6430-4D5D-A4DB-02199C8EF24EQ34652128-D9AFB050-E17E-43AC-86C9-FF74591BFC5EQ35202780-559639E8-EC11-4C78-B7AC-A5B158A2C81CQ35220381-07C310BD-EF73-4873-811C-FD7D1A731661Q35429682-F00B6415-40EB-4385-A9EE-A0E96F9B29ADQ36159988-9CE6E291-BE48-4095-92C9-898F77FFF144Q36777222-FB303CB8-E467-4A72-A503-181E98E0144AQ38219408-4DC3FF61-5D2A-4AF7-9A28-DCE67567D2DDQ39264877-8605165D-05ED-4F68-856C-D71C129078ADQ40106713-BDBA66AC-8C58-48B1-A2EB-AA86141443C7Q40329455-729B03E0-7F87-4527-A9BF-D6F31A62A432Q43664893-4178C0FB-F457-4CB1-9DA0-7A5AE37047BDQ45364783-32119492-8173-462C-89CD-DABBD54DD8C5Q46990391-EF895402-443C-45B0-8EE2-DC5CC8D98196Q48310565-4CD8D14E-8097-4AA8-8A07-BFFEC9DA03E5Q58089507-95D0EEB9-DF60-4513-9EDC-D93719F21741Q58802310-36C9E03A-25BA-4B9B-B2CD-36BF0E701320Q58803709-AF885C22-B052-4FD2-B0F6-AEFAD1D950EC
P2860
Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
@en
Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
@nl
type
label
Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
@en
Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
@nl
prefLabel
Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
@en
Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
@nl
P2093
P2860
P356
P1433
P1476
Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
@en
P2093
C F de Larrea
M T Cibeira
P2860
P2888
P304
P356
10.1038/LEU.2008.203
P577
2008-07-31T00:00:00Z
P5875
P6179
1027200598